Table 1: Patient characteristics, Surgery and Response Outcome.
Development cohort (n = 70) | Validation cohort (n = 55) | ||
---|---|---|---|
Age (years) | 64 (56–69) | 64 (56–70) | |
Sex | |||
Female | 23 (33%) | 13 (24%) | |
Male | 47 (67%) | 42 (76%) | |
Clinical tumor stage | |||
T2 | 12 (17%) | 0 (0%) | |
T3 | 55 (79%) | 46 (84%) | |
T4 | 3 (4%) | 9 (16%) | |
Clinical nodal stage | |||
N0 | 3 (4%) | 5 (9%) | |
N1 | 19 (27%) | 15 (27%) | |
N2 | 48 (69%) | 35 (64%) | |
Interval to Surgery (days) | 54 (49–56) | 55 (48–60) | |
Type of surgery | |||
Sphincter-sparing | 64 (91%) | 36 (65%) | |
APR | 4 (6%) | 18 (33%) | |
W&W | 2 (3%) | 0 (0%) | |
TEM | 0 (0%) | 1 (2%) | |
pCR (ypT0N0) | |||
No | 58 (83%) | 47 (85%) | |
Yes | 12 (17%) | 8 (15%) | |
Near-pCR (ypT0–1N0) | |||
No | 49 (70%) | 42 (76%) | |
Yes | 21 (30%) | 13 (24%) |